BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1922331)

  • 1. AIDS research turned upside down.
    Maddox J
    Nature; 1991 Sep; 353(6342):297. PubMed ID: 1922331
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross reaction. Could AIDS really be an autoimmune disease?
    Beardsley T
    Sci Am; 1991 Dec; 265(6):56-7. PubMed ID: 1754873
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus.
    Spear GT; Takefman DM; Sullivan BL; Landay AL; Jennings MB; Carlson JR
    Virology; 1993 Aug; 195(2):475-80. PubMed ID: 8337824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human trials of AIDS vaccines: current status and future directions.
    Koff WC; Fauci AS
    AIDS; 1989; 3 Suppl 1():S125-9. PubMed ID: 2558684
    [No Abstract]   [Full Text] [Related]  

  • 5. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS vaccine.
    Minn Med; 1991 Mar; 74(3):46. PubMed ID: 2030681
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
    Stahl-Hennig C; Coulibaly C; Petry H; Voss G; Dittmer U; Bodemer W; Makoschey B; Jurkiewicz E; Lüke W; Hunsmann G
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S27-32. PubMed ID: 7865316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of HIV vaccine development.
    Minor JR
    Am J Hosp Pharm; 1994 Jul; 51(14):1816-8. PubMed ID: 7942913
    [No Abstract]   [Full Text] [Related]  

  • 9. AIDS. Escape from the immune system.
    Walker BD; Goulder PJ
    Nature; 2000 Sep; 407(6802):313-4. PubMed ID: 11014174
    [No Abstract]   [Full Text] [Related]  

  • 10. Humoral immunity to HIV, SIV, and SHIV.
    Haigwood NL; Zolla-Pazner S
    AIDS; 1998; 12 Suppl A():S121-32. PubMed ID: 9632993
    [No Abstract]   [Full Text] [Related]  

  • 11. Animal models for HIV infection and AIDS: memorandum from a WHO meeting.
    Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Live attenuated viruses: a new strategy for vaccination against AIDS].
    Molina JM
    Pathol Biol (Paris); 1993 Jun; 41(6):513-4. PubMed ID: 8247628
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetically engineered vaccines for animal viral diseases.
    Yilma T
    J Am Vet Med Assoc; 1994 May; 204(10):1606-15. PubMed ID: 8050940
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor.
    Cohen J
    Science; 2004 Jun; 304(5676):1437. PubMed ID: 15178780
    [No Abstract]   [Full Text] [Related]  

  • 15. Does preserving memory correlate with surviving HIV?
    Horton H; De Rosa SC
    Trends Microbiol; 2007 Jan; 15(1):1-3. PubMed ID: 17112728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 neutralizing antibodies: how full is the bottle?
    Moore JP; Burton DR
    Nat Med; 1999 Feb; 5(2):142-4. PubMed ID: 9930854
    [No Abstract]   [Full Text] [Related]  

  • 17. 25 years of HIV research! ... and what about a vaccine?
    Appay V
    Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines. Monkey puzzles.
    Cohen J
    Science; 2002 Jun; 296(5577):2325-6. PubMed ID: 12089425
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy.
    Haynes BF; Yasutomi Y; Torres JV; Gardner MB; Langlios AJ; Bolognesi DP; Matthews TJ; Scearce RM; Jones DM; Moody MA
    Trans Assoc Am Physicians; 1993; 106():33-41. PubMed ID: 8036743
    [No Abstract]   [Full Text] [Related]  

  • 20. Prototype AIDS vaccine works in monkeys.
    Am Pharm; 1990 Feb; NS30(2):5. PubMed ID: 2106250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.